Global Pharmaceutical Membrane Filtration Market Overview
The key driver impacting the pharmaceutical membrane filtration market is the rapidly growing pharmaceutical and biopharmaceutical industry globally. For instance, as per the select USA, The United States is the biggest market for biopharmaceuticals, accounts for over a third of the global market. It is a worldwide leader in biopharmaceutical R&D. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), U.S. firms conduct over half the worldwide R&D of pharmaceuticals ($75 billion) and own the intellectual property rights on most new medicines. The industry accounted for more than $1.3 trillion in economic output, representing 4% of total U.S. output in 2015. As per the India Brand Equity Foundation, the Indian pharmaceutical market ranks 3rd worldwide for production by volume and 14th by value. The domestic pharmaceuticals market revenue reached $20.03 bn in 2019, which augmented by 9.3% from 2018. The market of the Pharma Industry in India is anticipated to attain $130 Bn by 2030. This will create a massive need to produce novel biologics that require uttermost sterility and minimal risks of contamination, which further needs the application of advanced filtration products to manufacture biologics and drugs. Moreover, the rising advancements in nanofiltration technology products are adding growth to the market in the coming years.
According to Value Market Research, the global pharmaceutical membrane filtration market size was valued at around USD 5750 million in 2020 and is estimated to grow at a CAGR of about 12.0% during the forecast period 2021 to 2027.
The high adoption of single-use technologies due to the benefits it provides is estimated to augment pharmaceutical membrane filtration needs in the forecast period. For instance, it is compact and takes up less space in the factory settings, minimizing the risk of contamination, reduces operation time, and provides ease of convenience. Also, the increasing R&D investments and activities by pharmaceutical and biotechnology companies in developing biologics are positively impacting the market growth. For instance, In 2018, Boehringer Ingelheim declared its plans to invest over USD 259 million for its new Biologicals Development Center (BDC), which would be located at its R&D site in Germany. However, high operation cost has been preventing many manufacturers from adopting the technology may hamper the market in the long run. Also, the membrane fouling issues are negatively impacting the market. The current industry trends, such as the commercial feasibility of track-etched membranes, are likely to provide market players with new market opportunities.
The Pharmaceutical membrane filtration market is vast, with many local and global players. The Pharmaceutical membrane filtration market is extensive, with many international and regional players. The key market leaders follow various strategies to advance their market statuses, such as amalgamation, extending product portfolio, contracts, product upgrades, and acquisitions, to enlarge their market share across the globe. For instance, The significant players studied in the report are Sartorius Stedim Biotech, Merck Millipore, Thermo Fisher Scientific, Danaher, 3M Company, Repligen Corporation, GEA Group, Koch Membrane Systems, Parker Hannifin, Graver Technologies, Porvair Plc., Novasep, Synder Corporation, Amazon Filters Ltd., Donaldson Company, Simsii, Alfa Laval, Meissner Filtration Products, Eaton Corporation, and Sterlitech Corporation.
In this research report, the Pharmaceutical membrane filtration market is segmented by product, technique, material, application, and region.
Analysis by Product:
By product, the report is categorized into filters, systems, and accessories. Membrane filters dominate the product segment with over 35% share in 2020. It is due to a versatile usage in a wide range of applications such as ultrafiltration, nanofiltration, microfiltration, and cross-flow filtration. Moreover, the rapid development of drugs and biologics companies and adoption development and manufacturing processes, including sterile filtration and end-stage processes, contribute to the high demand for membrane filters in the forecast period.
Analysis by Technique:
By technique, the report is segmented into microfiltration, ultrafiltration, nanofiltration, reverse osmosis, and ion exchange. Microfiltration dominates the technique segment with a 20% share in 2020. It is due to the rapid product advancement. Moreover, manufacturers extensively use the separation of large particles, including proteins and yeast, from a liquid feed stream, contributing to increased market demand in the forecast period.
Analysis by Materials:
By materials, the report is categorized into Polyethersulfone (PES), PVDF, Nylon, PTFE, MCE & CA, PCTE, and Other Materials. The Polyethersulfone segment dominates the materials segment with a 20% share in 2020. It is due to its extensive application in active pharmaceutical ingredient processing, protein purification, vaccine processing, antibody processing, and viral clearance. Moreover, advancements in technology such as cross-flow filtration, nanofiber, and ultrafiltration technology contribute to the enormous demand for polyethersulfone in the forecast period.
Analysis by Applications:
By applications, the report is categorized into final product processing, raw material filtration, cell separation, water purification, air purification. The Final Product Processing segment dominates the applications segment with a 25% share in 2020. It is due to the advancement in technology such as cross-flow filtration, nanofiber, and ultrafiltration technology. Moreover, the rising adoption of biologics and other therapeutic proteins has led to high protein purification processes in the pharmaceutical and biopharmaceutical industry, thus contributing to the enormous demand for pharmaceutical membrane filtration products in the forecast period.
Analysis by Region:
In the regional outlook of the global pharmaceutical membrane filtration market, the North America region dominates globally with a 30% market share in the forecast period. It is majorly due to the presence of key biopharmaceutical manufacturing facilities in the region and high spending on drug research and development (R&D) activities with easy access to advanced products. Moreover, the existence of well-established intellectual property systems for innovative biologics and healthcare infrastructure in this region contributes to its growth.
Market Segmentation covered in the Report:
By Product
- Filters
- Systems
- Accessories
By Technique
- Microfiltration
- Ultrafiltration
- Nanofiltration
- Reverse Osmosis
- Ion Exchange
By Material
- PES
- PVDF
- Nylon
- PTFE
- MCE & CA
- PCTE
- Other Materials (polypropylene, regenerated cellulose, gelatin, and PVC)
By Application
- Final Product Processing
- API Filtration
- Sterile Filtration
- Protein Purification
- Vaccine and Antibody Processing
- Formulation and Filling Solutions
- Viral Clearance
- Raw Material Filtration
- Media Buffers
- Prefiltration
- Bioburden Reduction
- Cell Separation
- Water Purification
- Air Purification
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.